Schon über 180 unheilbare Krebspatienten behandelt: Eine unbekannte Schweizer Firma steht vor dem Durchbruch (available only in German)

(English translation: Already treated over 180 incurable cancer patients: An unknown Swiss company is on the verge of a breakthrough)

Published in: TAGBLATT
Date: 16 August 2023

Gruppo Philogen: le nuove frontiere della medicina oncologica puntano sul targeting molecolare (available only in Italian)

(English translation: New frontiers in cancer medicine aim at molecular targeting)

Published in: Sole 24, Sanità 24
Date: 2 August 2023

Neue Niedermolekulare-Wirkstoffe-ML-Allianz (available only in German)

(English translation: New low-molecular-weight active substance ML alliance)

Published in: CHEMIEXTRA
Date: 1 July 2023

BioBoss Podcast #60 – Dario Neri: co-founder & CEO, Philogen

Published in: BioBoss
Date: 1 July 2023

Dario Neri e la corsa di Philogen. Biotech, Industria da esportare (available only in Italian)

Published in: Corriere della Sera
Date: 5 June 2023

Philogen Announces Clinical Trial Collaboration with MSD

Published in: Wallstreet Online
Date: 1 June 2023

Published in: The Economic Times
Date: 30 May 2023

Published in: la Repubblica
Date: 30 May 2023

Antibody-cytokine fusion breathes new life into glioblastoma therapy

Published in: Science Translational Medicine
Date: 24 May 2023

Immunotherapy turned brain cancers from ‘cold’ to ‘hot’ in mouse study, as clinical trials advance

Published in: STAT
Date: 24 May 2023

New opportunities for small molecules in cancer

Published in: MedNous
Date: 20 May 2023

Using ML with DEL: Philogen and Google Partner in New Study

Published in: Oxford Global
Date: 28 March 2023

Industrial PhD: My way to go?

Published in: Chem (Cell)
Date: 31 January 2023